GSK statement on MHRA Seroxat investigation
No suicides were reported in any of the nine paediatric trials conducted by GSK. – GlaxoSmithKline (GSK) notes the conclusions announced by the Medicines and Healthcare products Regulatory Agency (MHRA) regarding its investigation into disclosure of paediatric trial data for the anti-depressant medicine Seroxat (paroxetine).